Sustained improvement of arterial stiffness and blood pressure after long-term rosuvastatin treatment in patients with inflammatory joint diseases: Results from the rora-as study

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Ikdahl, Eirik ^a   Rollefstad, Silvia ^a   Hisdal, Jonny ^b   Olsen, Inge C ^a   Pedersen, Terje R ^c,d   Kvien, Tore K ^a   Semb, Anne Grete ^a  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b AKER UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANKYLOSING SPONDYLITIS; AORTIC PULSE WAVE VELOCITY; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; CAROTID ATHEROSCLEROSIS; CLINICAL TRIAL (TOPIC); CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG DOSE INCREASE; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PSORIATIC ARTHRITIS; PULSE WAVE; RHEUMATOID ARTHRITIS; SYSTOLIC BLOOD PRESSURE; AORTA; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; DRUG EFFECTS; INFLAMMATION; JOINT DISEASES; METABOLISM; MIDDLE AGED; PROCEDURES; RISK FACTOR; SPONDYLITIS, ANKYLOSING;

AGED; AORTA; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; JOINT DISEASES; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; RISK FACTORS; ROSUVASTATIN CALCIUM; SPONDYLITIS, ANKYLOSING; VASCULAR STIFFNESS;

EID: 84964689429     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153440     Document Type: Article

References (36)

1. Hollan I, Meroni PL, Ahearn JM, Cohen Tervaert JW, Curran S, Goodyear CS et al. Cardiovascular disease in autoimmune rheumatic diseases. Autoimm Rev. 2013;12:1004-15.
2. Han C, Robinson DW Jr., Hackett MV, Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006;33:2167-72. PMID: 16981296
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr. etal. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52. PMID: 14656957
4. Gonzalez A, Maradit-Kremers H, Crowson CS, Ballmann KV, Roger VL, Jacobsen SJ et al. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis. 2008;67:64-9. PMID: 17517756
5. Panoulas VF, Metsios GS, Pace AV, John H, Treharne GJ, Banks MJ et al. Hypertension in rheumatoid arthritis. Rheumatology. 2008;47:1286-98. doi: 10.1093/rheumatology/ken159 PMID: 18467370
6. Roman MJ, Moeller E, Davis A, Paget SA, Crow MK, Lockshin MD et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med. 2006;144:249-56. PMID: 16490910
7. Cypiene A, Dadoniene J, Rugiene R, Ryliskyte L, Kovaite M, Petrulioniene Z et al. The influence of mean blood pressure on arterial stiffening and endothelial dysfunction in women with rheumatoid arthritis and systemic lupus erythematosus. Medicina. 2010;46:522-30. PMID: 20966628
8. Boutouyrie P, Lacolley P, Briet M, Regnault V, Stanton A, Laurent S et al. Pharmacological modulation of arterial stiffness. Drugs. 2011;71:1689-701. doi: 10.2165/11593790-000000000-00000 PMID: 21902292
9. Provan SA, Semb AG, Hisdal J, Stranden E, Agewall S, Dagfinrud H et al. Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study. Ann Rheum Dis. 2011;70:812-7. doi: 10.1136/ard.2010.141523 PMID: 21288959
10. Bodnar N, Kerekes G, Seres I, Paragh G, Kappelmayer J, Nemethne ZG et al. Assessment of subclinical vascular disease associated with ankylosing spondylitis. J Rheumatol. 2011;38:723-9. doi: 10. 3899/jrheum.100668 PMID: 21239756
11. Costa L, Caso F, D'Elia L, Atteno M, Peluso R, Del Puente A et al. Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study. Clin Rheumatol. 2012;31:711-5. doi: 10.1007/s10067-011-1892-1 PMID: 22113824
12. Mattace-Raso FU, Van Der Cammen TJ, Hofman A, Van Popele NM, Bos ML, Schalekamp MA et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113:657-63. PMID: 16461838
13. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004;109:184-9. PMID: 14662706
14. McCarey DW, McInnes IB, Madhok R, Hampson R, Scher Bakoc O, Ford I et al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet. 2004;363:2015-21. PMID: 15207950
15. Rollefstad S, Kvien TK, Holme I, Eirheim AS, Pedersen TR, Semb AG. Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic. Ann Rheum Dis. 2013;72:1968-74. doi: 10.1136/annrheumdis-2012-202789 PMID: 23264359
16. Rollefstad S, Ikdahl E, Hisdal J, Olsen IC, Smerud KT, Kitas G, Pedersen TR, Kvien TK, Semb AG. Rosuvastatin induced carotid plaque regression in patients with inflammatory joint diseases. Arthritis Rheum. Published online first: 2015 Mar. 16. doi: 10.1002/art.39114
17. Van Doornum S, Mc Coll G, Wicks IP. Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. Ann Rheum Dis. 2004;63:1571-5. PMID: 15547080
18. Maki-Petaja KM, Booth AD, Hall FC, Wallace SM, Brown J, McEniery CM et al. Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol. 2007;50:852-8. PMID: 17719471
19. Hongo M, Tsutsui H, Mawatari E, Hidaka H, Kumzaki S, Yazaki Y et al. Fluvastatin improves arterial stiffness in patients with coronary artery disease and hyperlipidemia: a 5-year follow-up study. Circ J. 2008;72:722-8. PMID: 18441450
20. Briasoulis A, Agarwal V, Valachis A, Messerli FH. Antihypertensive effects of statins: a meta-analysis of prospective controlled studies. J Clin Hypertens. 2013;15:310-20.
21. Strazzullo P, Kerry SM, Barbato A, Versiero M, D'Elia L, Cappuccio FP. Do statins reduce blood pressure?: a meta-analysis of randomized, controlled trials. Hypertension. 2007;49:792-8. PMID: 17309949
22. Roman MJ, Naqvi TZ, Gardin JM, Gerhard-Herman M, Jaff M, Mohler E et al. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiog. 2006;19:943-54.
23. Stoner L, Faulkner J, Lowe A, M Lambrick D, M Young J, LOVE R et al. Should the augmentation index be normalized to heart rate? J AtherosclerThromb. 2014;21:11-6. PMID: 24257465
24. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38:932-7. PMID: 11641312
25. Angel K, Provan SA, Hammer HB, Mowinckel P, Kvien TK, Atar D. Changes in arterial stiffness during continued infliximab treatment in patients with inflammatory arthropathies. Fund Clin Pharmacol. 2011;25:511-7.
26. Ubels FL, Muntinga JH, Van Doormaal JJ, Reitsma WD, Smit AJ. Effects of initial and long-term lipidlowering therapy on vascular wall characteristics. Atherosclerosis. 2001;154:155-61. PMID: 11137095
27. Borghi C, Dormi A, Veronesi M, Sangiorgi Z, Gaddi A, Brisighella Heart Study Working P. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study. Am Heart J. 2004;148:285-92. PMID: 15308998
28. Shige H, Dart A, Nestel P. Simvastatin improves arterial compliance in the lower limb but not in the aorta. Atherosclerosis. 2001;155:245-50. PMID: 11223448
29. Ferrier KE, Muhlmann MH, Baguet JP, Cameron JD, Jennings GL, Dart AM et al. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol. 2002;39:1020-5. PMID: 11897445
30. Payne RA, Wilkinson IB, Webb DJ. Arterial stiffness and hypertension: emerging concepts. Hypertension. 2010;55:9-14. doi: 10.1161/HYPERTENSIONAHA.107.090464 PMID: 19948990
31. Mitchell GF. Arterial stiffness and hypertension: chicken or egg? Hypertension. 2014;64:210-4. doi: 10.1161/HYPERTENSIONAHA.114.03449 PMID: 24799614
32. Kelly RP, Millasseau SC, Ritter JM, Chowienczyk PJ. Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension. 2001;37:1429-33. PMID: 11408390
33. Bramwell J. Velocity of transmission of the pulse-wave. Lancet. 1922;5149:891-2.
34. Merillon JP, Lebras Y, Chastre J, Lerallut JF, Motte G, Fontenier G et al. Forward and backward waves in the arterial system, their relationship to pressure waves form. Eur Heart J. 1983;4 Suppl G: 13-20. PMID: 6662117
35. Nichols WW. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms. Am J Hypertens. 2005;18:3S-10S. PMID: 15683725
36. Alghatrif M, Strait JB, Morrell CH, Canepa M, Wright J, Elangpo P et al. Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging. Hypertension. 2013;62:934-41. doi: 10.1161/HYPERTENSIONAHA.113.01445 PMID: 24001897